Literature DB >> 11554611

Metformin, but not exercise training, increases insulin responsiveness in skeletal muscle of Sprague-Dawley rats.

S E Borst1, H G Snellen.   

Abstract

We assessed the effects of combined metformin treatment and exercise training on body composition, on insulin concentration following glucose loading, on insulin-stimulated glucose transport in skeletal muscle, and on muscle glycogen content. Male Sprague-Dawley rats were treated for 35 days with or without metformin (320 mg/kg/day) and/or treadmill exercise training (20 min at 20 m/min, 5 days/wk). Because metformin reduces food intake, pair-fed controls were included. Metformin, training, and pair-feeding all decreased food intake, body weight, and insulin concentration following glucose loading. Metformin and training reduced intra-abdominal fat, but pair feeding did not. In isolated strips derived from soleus, epitrochlearis and extensor carpi ulnaris muscles, metformin increased insulin-stimulated transport of [3H]-2-deoxyglucose by 90%, 89% and 125%, respectively (P < 0.02) and training increased [3H]-2-deoxyglucose transport in the extensor carpi ulnaris muscle only (66%, P < 0.05). Pair-feeding did not alter [3H]-2-deoxyglucose transport. Training increased gastrocnemius muscle glycogen by 100% (P < 0.001). Metformin and pair-feeding did not alter muscle glycogen. We conclude that metformin reverses the maturation-induced impairment of insulin responsiveness in Sprague-Dawley rats by increasing insulin-stimulated glucose transport in skeletal muscle and that this effect is not secondary to reduced food intake. We also conclude that metformin and exercise training may increase insulin sensitivity by different mechanisms, with training causing increased glucose transport only in some muscles and also causing increased muscle glycogen storage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11554611     DOI: 10.1016/s0024-3205(01)01225-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.

Authors:  V Luna; L Casauban; M P Sajan; J Gomez-Daspet; J L Powe; A Miura; J Rivas; M L Standaert; R V Farese
Journal:  Diabetologia       Date:  2006-01-05       Impact factor: 10.122

Review 2.  Of mice and men: the benefits of caloric restriction, exercise, and mimetics.

Authors:  Evi M Mercken; Bethany A Carboneau; Susan M Krzysik-Walker; Rafael de Cabo
Journal:  Ageing Res Rev       Date:  2011-12-20       Impact factor: 10.895

3.  Metformin enhances insulin signalling in insulin-dependent and-independent pathways in insulin resistant muscle cells.

Authors:  Naresh Kumar; Chinmoy S Dey
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

4.  Metformin does not enhance insulin-stimulated vasodilation in skeletal muscle resistance arteries of the OLETF rat.

Authors:  Jacqueline M Crissey; Jaume Padilla; Nathan T Jenkins; Jeffrey S Martin; Randy Scott Rector; John P Thyfault; Maurice Harold Laughlin
Journal:  Microcirculation       Date:  2013-11       Impact factor: 2.628

5.  Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension.

Authors:  C Agard; M Rolli-Derkinderen; E Dumas-de-La-Roque; M Rio; C Sagan; J P Savineau; G Loirand; P Pacaud
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

6.  Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine.

Authors:  Mingyan Zhou; Li Xia; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2007-06-28       Impact factor: 3.922

7.  Two weeks of metformin treatment induces AMPK-dependent enhancement of insulin-stimulated glucose uptake in mouse soleus muscle.

Authors:  Jonas Møller Kristensen; Jonas T Treebak; Peter Schjerling; Laurie Goodyear; Jørgen F P Wojtaszewski
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-03-18       Impact factor: 4.310

8.  Two weeks of metformin treatment enhances mitochondrial respiration in skeletal muscle of AMPK kinase dead but not wild type mice.

Authors:  Jonas M Kristensen; Steen Larsen; Jørn W Helge; Flemming Dela; Jørgen F P Wojtaszewski
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

9.  Metformin attenuates ventilator-induced lung injury.

Authors:  George Tsaknis; Ilias I Siempos; Petros Kopterides; Nikolaos A Maniatis; Christina Magkou; Matina Kardara; Stefania Panoutsou; Anastasia Kotanidou; Charis Roussos; Apostolos Armaganidis
Journal:  Crit Care       Date:  2012-07-24       Impact factor: 9.097

10.  Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions.

Authors:  Jie Sha; Jungsik Na; Jung Ok Lee; Nami Kim; Soo Kyung Lee; Ji Hae Kim; Ji Wook Moon; Su Jin Kim; Hye Jeong Lee; Jong-Il Choi; Sun Hwa Park; Hyeon Soo Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2014-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.